CoChat

Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations

Open access
Samant, Tanay S., Dhuria, Shyeilla, Lu, Yasong, Laisney, Marc, Yang, Shu, Grandeury, Arnaud, Mueller‐Zsigmondy, Martin, Umehara, Kenichi, Huth, Felix, Miller, Michelle, Germa, Caroline, Elmeliegy, Mohamed · 2018 · Clinical Pharmacology & Therapeutics
Cited by 82

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Ribociclib (KISQALI), a cyclin‐dependent kinase 4/6 inhibitor approved for the first‐line treatment of HR+/HER2– advanced breast cancer with an aromatase inhibitor, is administered with no restrictions on concomitant gastric pH‐elevating agents or food intake. The influence of proton pump inhibitors (PPIs) on ribociclib bioavailability was assessed using 1) biorelevant media solubility, 2) physiologically based pharmacokinetic (PBPK) modeling, 3) noncompartmental analysis (NCA) of clinical trial data, and 4) population PK (PopPK) analysis. This multipronged approach indicated no effect of gastric pH changes on ribociclib PK and served as a platform for supporting ribociclib labeling language, stating no impact of gastric pH‐altering agents on the absorption of ribociclib, without a dedicated drug–drug interaction trial. The bioequivalence of ribociclib exposure with or without a high‐fat meal was demonstrated in a clinical trial. Lack of restrictions on ribociclib dosing may facilitate better patient compliance and therefore clinical benefit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cpt.940

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 82

Metadata

Authors
Samant, T. S., Dhuria, S., Lu, Y., Laisney, M., Yang, S., Grandeury, A., Mueller‐Zsigmondy, M., Umehara, K., Huth, F., Miller, M., Germa, C., & Elmeliegy, M.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2017-12-08
Volume
104
Issue
2
Pages
374-383
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2769143729
Cited by
82
References
12
FWCI
2.66
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations. https://app.cochat.ai/papers/10.1002/cpt.940
The paper
Samant, T. S., Dhuria, S., Lu, Y., Laisney, M., Yang, S., Grandeury, A., Mueller‐Zsigmondy, M., Umehara, K., Huth, F., Miller, M., Germa, C., & Elmeliegy, M. (2018). Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.940

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.